Published 2013 | Version v1
Publication

Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines

Additional details

Created:
March 27, 2023
Modified:
November 29, 2023